M Vogelhuber

Author PubWeight™ 0.76^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial.	J Eur Acad Dermatol Venereol	2015	0.76